RPG Life Sciences Limited - Asset Resilience Ratio

Latest as of March 2026: 10.58%

RPG Life Sciences Limited (RPGLIFE) has an Asset Resilience Ratio of 10.58% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs839.00 Million
≈ $9.07 Million USD Cash + Short-term Investments

Total Assets

Rs7.93 Billion
≈ $85.78 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2026)

This chart shows how RPG Life Sciences Limited's Asset Resilience Ratio has changed over time. Check RPG Life Sciences Limited PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down RPG Life Sciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is RPG Life Sciences Limited worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs839.00 Million 10.58%
Total Liquid Assets Rs839.00 Million 10.58%

Asset Resilience Insights

  • Moderate Liquidity: RPG Life Sciences Limited has 10.58% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

RPG Life Sciences Limited Industry Peers by Asset Resilience Ratio

Compare RPG Life Sciences Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for RPG Life Sciences Limited (2017–2026)

The table below shows the annual Asset Resilience Ratio data for RPG Life Sciences Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 10.58% Rs839.00 Million
≈ $9.07 Million
Rs7.93 Billion
≈ $85.78 Million
-29.24pp
2025-03-31 39.81% Rs2.62 Billion
≈ $28.32 Million
Rs6.58 Billion
≈ $71.14 Million
+15.80pp
2024-03-31 24.01% Rs1.23 Billion
≈ $13.32 Million
Rs5.13 Billion
≈ $55.46 Million
-5.13pp
2023-03-31 29.14% Rs1.22 Billion
≈ $13.22 Million
Rs4.19 Billion
≈ $45.35 Million
+25.41pp
2022-03-31 3.73% Rs128.60 Million
≈ $1.39 Million
Rs3.45 Billion
≈ $37.27 Million
+3.23pp
2021-03-31 0.50% Rs15.30 Million
≈ $165.46K
Rs3.03 Billion
≈ $32.81 Million
+0.46pp
2020-03-31 0.04% Rs1.20 Million
≈ $12.98K
Rs2.67 Billion
≈ $28.85 Million
0.00pp
2019-03-31 0.05% Rs1.20 Million
≈ $12.98K
Rs2.51 Billion
≈ $27.17 Million
-0.24pp
2018-03-31 0.28% Rs8.30 Million
≈ $89.76K
Rs2.91 Billion
≈ $31.50 Million
+0.08pp
2017-03-31 0.20% Rs5.00 Million
≈ $54.07K
Rs2.46 Billion
≈ $26.63 Million
--
pp = percentage points

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$493.09 Million
Rs45.59 Billion INR
Market Cap Rank
#12149 Global
#615 in India
Share Price
Rs2756.80
Change (1 day)
-0.41%
52-Week Range
Rs1744.00 - Rs3017.10
All Time High
Rs3017.10
About

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more